Skip navigation

Merck & Co. Inc.

NYS : MRK
Pharmaceuticals
Whitehouse Station NJ
2013 Revenue (US$ Millions)$44,033
2012 Revenue (US$ Millions)$47,267
Revenue Growth (%)-6.84%
Net Income (US$ Millions)$4,404
Common Shares Outstanding (Millions)$2,928
Earnings Per Share (US$)$1.47
Price To Earnings Ratio50.18
Total Equity (US$ Millions)$49,765
Profit Margin (%)10.00%
Return On Equity (%)8.31%
Long Term Debt (US$ Millions)$20,539
Debt To Equity Ratio (%)0.41%
Market Capitalization (US$ Millions)$146,523
Total Assets (US$ Millions)$105,645
Return on Assets (%)4.15
Current Assets (US$ Millions)$35,685
Inventories (US$ Millions)$6,226
Current Liabilities (US$ Millions)$17,868
Cost of Goods Sold (US$ Millions)$16,954
Asset Turnover0.42
Inventory Turnover2.66
ExchangeNYS